Pablo J. Cagnoni, Director: Rubius Therapeutics RUBY Sell · Filed 23/01/31

Trade details

Type: Insider sale
Amount: $1,737.6
Shares · price: 7,240 sh · $0.24 a share
Held after: 74,530 sh
Stock: Rubius Therapeutics RUBY
Person: Pablo J. CagnoniDirector
Trade date: 23/01/31
Filed: 23/01/31
Days to filing: 0 days

Sold 8.9% of holdings

Share of holding sold: 8.9%

Rubius Therapeutics trades, last 26 weeks

What else happened in Rubius Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/01~23/03/02

Pablo J. Cagnoni's recent trades

Pablo J. CagnoniPresident, Global Head of R&D
Planned sale10b5-1 planIncyte
Planned sale10b5-1 plan
Incyte
INCY
$2.8M
23,218 sh
$2.8M
Filed 09/15
Traded 09/15
Pablo J. CagnoniPresident, Global Head of R&D
Planned sale10b5-1 planIncyte
Planned sale10b5-1 plan
Incyte
INCY
$1.4M
10,801 sh
$1.4M
Filed 08/19
Traded 08/19
Pablo J. CagnoniPresident, Global Head of R&D
Planned sale10b5-1 planIncyte
Planned sale10b5-1 plan
Incyte
INCY
$1.3M
10,803 sh
$1.3M
Filed 08/12
Traded 08/12
Pablo J. CagnoniPresident, Global Head of R&D
Planned sale10b5-1 planIncyte
Planned sale10b5-1 plan
Incyte
INCY
$1.3M
10,640 sh
$1.3M
Filed 08/05
Traded 08/05
Pablo J. CagnoniPresident, Global Head of R&D
Planned sale10b5-1 planIncyte
Planned sale10b5-1 plan
Incyte
INCY
$1.9M
15,888 sh
$1.9M
Filed 07/31
Traded 07/31